{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304175/0/en/Actuate-Therapeutics-Announces-ASCO-Poster-Presentations-Demonstrating-Compelling-Clinical-and-Biomarker-Data-for-Elraglusib-in-First-Line-Metastatic-Pancreatic-Cancer.html", "message": "News view counter 769559 successfully enlarged"}